← Back to catalogue

ipsogen® JAK2 RGQ PCR Kit

FDA UDI

Class II (US FDA UDI)

by Qiagen, Inc.

Identity

Trade Name
ipsogen® JAK2 RGQ PCR Kit FDA UDI
Generic Name
JAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
V1 FDA UDI

Identifiers

Catalog Number
673633 FDA UDI
Primary DI / UDI-DI
04053228015444 FDA UDI
510(k) Number
FDA Product Code
PSU FDA UDI
GMDN Term
JAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.6070 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: JAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT)

ipsogen® JAK2 RGQ PCR Kit by Qiagen, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Qiagen, Inc.

Sources (1)

  • FDA UDI fa80cd90-2364-441f-b62b-02e7b1f960d9 34 fields · synced May 31, 2026